Alexa Folco

Alexa Folco is an associate in the firm’s Business Law department and a member of its Life Sciences group. She represents public companies and investment banks in connection with a variety of capital markets transactions. She also advises public companies on securities law compliance and corporate governance matters.

• Upstream Bio, Inc. in connection with its $293.0 million upsized initial public offering
• Rapport Therapeutics Inc. in connection with its $174.0 million initial public offering and concurrent private placement
• Prime Medicine, Inc. in connection with its upsized $140.0 million follow-on offering
• Sagimet Biosciences Inc. in connection with its $112.5 million follow-on offering
• Q32 Bio Inc. in connection with its definitive merger agreement to combine with Homology Medicines, Inc. and concurrent financing
• Valvoline Inc. in connection with its $1.0 billion modified “Dutch auction” tender offer*
• SPX Corporation in connection with its corporate legal structure reorganization*
• Paramount Global in connection with its offering of $1.0 billion fixed-to-fixed rate junior subordinated debentures*
• The underwriter(s) in connection with:
• PACS Group, Inc.’s upsized $450.0 million initial public offering
• Mineralys Therapeutics, Inc.’s upsized $220.8 million initial public offering*
• Myriad Genetics, Inc.’s $110.0 million follow-on offering
• Procept BioRobotics Corporation’s $172.5 million follow-on offering*
• Inari Medical, Inc.’s $162.0 million follow-on offering*
• Tarsus Pharmaceuticals, Inc.’s $75.6 million follow-on offering*
• Tidewater, Inc.’s $72.3 million and $120.6 million follow-on offerings*
• The placement agent(s) in connection with:
• Sonendo, Inc.’s private placement offering of $66.0 million of common stock and pre-funded warrants*
• 5E Advanced Materials, Inc.’s private placement offering of $60.0 million of secured convertible notes*
• Ambipar Emergency Response’s business combination with HPX Corp. and a related private placement*

* Denotes experience prior to joining Goodwin.

Prior to joining Goodwin in 2023, Alexa was an associate in the Capital Markets practice group at Shearman & Sterling LLP.